Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 28, 2021

SELL
$47.2 - $67.81 $177,236 - $254,626
-3,755 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$30.93 - $59.48 $116,142 - $223,347
3,755 New
3,755 $209,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.73B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Nicollet Investment Management, Inc. Portfolio

Follow Nicollet Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicollet Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicollet Investment Management, Inc. with notifications on news.